Cystic Fibrosis (CF)

Phase 2 Study to Assess the Safety and Efficacy of ANG003

Heart and Blood Vessels Health in People With Cystic Fibrosis

Autogenic Drainage Versus Mechanical Percussion in Children With Cystic Fibrosis

Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection

Rethinking Early Airway Clearence Therapies

Verapamil Effect in Cystic Fibrosis-related Dysglycemia

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

Safety of Stopping Pancreatic Enzyme Replacement Therapy in Children With Improved Pancreatic Function After Highly Effective Modulator Therapy

Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet

Study to Enable New Diagnostics for Pulmonary Microbes in People With CF

Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease

Home Air Pollution in Children With Cystic Fibrosis Study

Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis

Nutrition Supplement for Cystic Fibrosis

Pharmacokinetics of Antibiotics in Patients With Cystic Fibrosis Trated With Elexacaftor/Tezacaftor/Ivacaftor (ETI)

Ensuring Access to Optimal Therapy in CF: The ENACT Study

The School-Age Children With Cystic Fibrosis and Their Parents on Health Literacy

Muscle Fatigue in People With Cystic Fibrosis: Insight From a Mobile App

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta